ARCHIVES

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

This article is from The Cancer Letter archive.

Vol. 01 No. 49 | December 5, 1975

Download PDF Visit The Full Archive

Related Articles

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says

March 5, 1993

NCI Funds; Ad Hoc Group Approves NCCTG Renewal

September 18, 1981

OMB Budget Revision Would Cut Centers $20 Million, Slash Clinical Education, Training, Contracts Funds

April 22, 1983

Avoiding Mediastinal Radiation Can Improve Patient Outcomes

April 26, 2013

In Brief: Alice Fordyce, Supporter of Medical Research, Dead At 86; Broder Awarded Block Lectureship

September 18, 1992